Exam 3 NURS 5410 Pain
問題一覧
1
Applying a local anesthetic to numb the tissue and block nociceptive signaling from the site of injury
2
To alert the body to potential tissue damage and prevent further harm
3
Prescribing a medication that targets nerve pain, such as an anticonvulsant, to manage ongoing neuropathic sensations
4
Persistent pain due to nerve damage, often causing burning or shooting sensations without external triggers
5
Utilizing psychotherapy to address emotional distress and reduce the mind-body manifestation of pain
6
Pain that arises without physical damage, linked to emotional or mental distress
7
Providing a local anesthetic for nociceptive pain and prescribing an anticonvulsant for neuropathic pain
8
Psychogenic pain arises from psychological causes, whereas nociceptive and neuropathic pain have physical origins
9
Aδ fibers
10
Sharp, immediate pain in response to injury
11
C fibers
12
Prolonged, dull, and intense pain
13
Aβ fibers for touch, Aδ fibers for quick pain, and C fibers for prolonged pain
14
Aδ fibers carry immediate, sharp pain via myelinated fibers, while C fibers transmit slower, persistent pain through unmyelinated fibers
15
By stimulating Aβ fibers to transmit non-painful signals, which inhibit pain at the spinal cord level
16
Non-painful stimuli activate Aβ fibers, which can inhibit pain signals at the spinal cord level
17
Rubbing activates Aβ fibers, which transmit non-painful signals that inhibit pain transmission in the spinal cord
18
Rubbing stimulates Aβ fibers, which inhibit pain signals at the spinal cord level
19
Dorsal horn neurons in the spinothalamic tract projecting to the thalamus and primary somatosensory cortex
20
Spinothalamic tract, where dorsal horn neurons project to the thalamus and primary somatosensory cortex
21
Sensory/discriminatory pathway
22
To enable the brain to identify where pain is occurring and assess its severity
23
Affective-motivational pathway, where neurons in the spinobulbar tract project to brainstem nuclei, thalamus, and limbic structures
24
Affective-motivational pathway, involving the spinobulbar tract to brainstem nuclei, thalamus, and limbic structures
25
Affective-motivational pathway, which conveys emotional reactions and avoidance motivations related to pain
26
To transmit emotional and motivational responses, creating the desire to avoid the painful stimulus
27
Combining cognitive-behavioral therapy (CBT) for emotional processing with analgesics for pain reduction, addressing both pathways in pain perception
28
The integration of sensory/discriminatory and affective/motivational pathways, combining physical and emotional dimensions
29
Implementing a multimodal approach that combines analgesics to manage physical pain with cognitive-behavioral therapy (CBT) to address the emotional context of pain
30
To process sensory and emotional dimensions together, making pain a fully conscious experience
31
Applying anti-inflammatory medication to reduce swelling and manage pain as the injury heals
32
It results from direct injury and typically resolves once the underlying cause heals
33
Encouraging the use of cognitive-behavioral therapy (CBT) to address central sensitization and coping strategies for persistent pain
34
Chronic pain persists beyond normal healing periods and involves changes in pain pathways
35
Encouraging physical therapy for the wrist sprain while recommending cognitive-behavioral therapy (CBT) to help the patient with chronic back pain manage long-term discomfort
36
Acute pain is a response to direct injury with a clear healing timeline, whereas chronic pain persists due to sensitization and often lacks a defined endpoint
37
Monitoring respiratory function due to the risk of respiratory depression
38
To mediate pain relief, euphoria, and respiratory depression when activated by opioids
39
Improved mood regulation with additional analgesic effects and potentially fewer side effects
40
To modulate mood and provide additional pain relief, often with fewer side effects than mu receptors
41
Kappa receptors cause dysphoria and can lead to hallucinations, which may limit their use
42
They induce pain relief but are often accompanied by dysphoria and potential hallucinations
43
Kappa receptors, as they provide pain relief without euphoria, though they may cause dysphoria
44
Mu receptors are most commonly targeted for their potent pain relief but have a higher addiction risk compared to delta and kappa receptors
Patho Renal
Patho Renal
Two Clean Queens · 100問 · 2年前Patho Renal
Patho Renal
100問 • 2年前Pathophysiology
Pathophysiology
Two Clean Queens · 100問 · 2年前Pathophysiology
Pathophysiology
100問 • 2年前Patho Immunology
Patho Immunology
Two Clean Queens · 34問 · 2年前Patho Immunology
Patho Immunology
34問 • 2年前Patho Hematology
Patho Hematology
Two Clean Queens · 100問 · 2年前Patho Hematology
Patho Hematology
100問 • 2年前Patho Hematology 2
Patho Hematology 2
Two Clean Queens · 76問 · 2年前Patho Hematology 2
Patho Hematology 2
76問 • 2年前Patho Respiratory
Patho Respiratory
Two Clean Queens · 100問 · 2年前Patho Respiratory
Patho Respiratory
100問 • 2年前Patho Respiratory 2
Patho Respiratory 2
Two Clean Queens · 54問 · 2年前Patho Respiratory 2
Patho Respiratory 2
54問 • 2年前Patho Cardiovascular
Patho Cardiovascular
Two Clean Queens · 100問 · 2年前Patho Cardiovascular
Patho Cardiovascular
100問 • 2年前Patho Cardiovascular 2
Patho Cardiovascular 2
Two Clean Queens · 56問 · 2年前Patho Cardiovascular 2
Patho Cardiovascular 2
56問 • 2年前Patho MSK
Patho MSK
Two Clean Queens · 52問 · 2年前Patho MSK
Patho MSK
52問 • 2年前Patho Acid Base
Patho Acid Base
Two Clean Queens · 35問 · 2年前Patho Acid Base
Patho Acid Base
35問 • 2年前Renal 2
Renal 2
Two Clean Queens · 10問 · 2年前Renal 2
Renal 2
10問 • 2年前Fluid Balance
Fluid Balance
Two Clean Queens · 43問 · 2年前Fluid Balance
Fluid Balance
43問 • 2年前Patho Endocrine
Patho Endocrine
Two Clean Queens · 100問 · 2年前Patho Endocrine
Patho Endocrine
100問 • 2年前Patho Endocrine 2
Patho Endocrine 2
Two Clean Queens · 42問 · 2年前Patho Endocrine 2
Patho Endocrine 2
42問 • 2年前Infections
Infections
Two Clean Queens · 58問 · 2年前Infections
Infections
58問 • 2年前Patho Shock
Patho Shock
Two Clean Queens · 31問 · 2年前Patho Shock
Patho Shock
31問 • 2年前GI
GI
Two Clean Queens · 100問 · 2年前GI
GI
100問 • 2年前GI 2
GI 2
Two Clean Queens · 18問 · 2年前GI 2
GI 2
18問 • 2年前Cancer
Cancer
Two Clean Queens · 54問 · 2年前Cancer
Cancer
54問 • 2年前Neuro
Neuro
Two Clean Queens · 94問 · 2年前Neuro
Neuro
94問 • 2年前Psychopathology
Psychopathology
Two Clean Queens · 20問 · 2年前Psychopathology
Psychopathology
20問 • 2年前Bone Pharm
Bone Pharm
Two Clean Queens · 77問 · 2年前Bone Pharm
Bone Pharm
77問 • 2年前Urology Pharm
Urology Pharm
Two Clean Queens · 68問 · 2年前Urology Pharm
Urology Pharm
68問 • 2年前Lifestyle Considerations Outline_Pharm
Lifestyle Considerations Outline_Pharm
Two Clean Queens · 97問 · 2年前Lifestyle Considerations Outline_Pharm
Lifestyle Considerations Outline_Pharm
97問 • 2年前Prescribing Basics Outline_Pharm
Prescribing Basics Outline_Pharm
Two Clean Queens · 23問 · 2年前Prescribing Basics Outline_Pharm
Prescribing Basics Outline_Pharm
23問 • 2年前Pharmacokinetics_Pharm
Pharmacokinetics_Pharm
Two Clean Queens · 31問 · 2年前Pharmacokinetics_Pharm
Pharmacokinetics_Pharm
31問 • 2年前Diabetes Pharm
Diabetes Pharm
Two Clean Queens · 100問 · 2年前Diabetes Pharm
Diabetes Pharm
100問 • 2年前Diabetes Pharm 2
Diabetes Pharm 2
Two Clean Queens · 41問 · 2年前Diabetes Pharm 2
Diabetes Pharm 2
41問 • 2年前Neuroendocrine Obesity Pharm
Neuroendocrine Obesity Pharm
Two Clean Queens · 100問 · 2年前Neuroendocrine Obesity Pharm
Neuroendocrine Obesity Pharm
100問 • 2年前Neuroendocrine Obesity Pharm 2
Neuroendocrine Obesity Pharm 2
Two Clean Queens · 43問 · 2年前Neuroendocrine Obesity Pharm 2
Neuroendocrine Obesity Pharm 2
43問 • 2年前Dermatology Pharm
Dermatology Pharm
Two Clean Queens · 106問 · 1年前Dermatology Pharm
Dermatology Pharm
106問 • 1年前Dermatology Pharm 2
Dermatology Pharm 2
Two Clean Queens · 24問 · 1年前Dermatology Pharm 2
Dermatology Pharm 2
24問 • 1年前Cardiac/Renal Pharm 1
Cardiac/Renal Pharm 1
Two Clean Queens · 100問 · 1年前Cardiac/Renal Pharm 1
Cardiac/Renal Pharm 1
100問 • 1年前Cardiac/Renal Pharm 2
Cardiac/Renal Pharm 2
Two Clean Queens · 100問 · 1年前Cardiac/Renal Pharm 2
Cardiac/Renal Pharm 2
100問 • 1年前Cardiac/Renal Pharm 3
Cardiac/Renal Pharm 3
Two Clean Queens · 86問 · 1年前Cardiac/Renal Pharm 3
Cardiac/Renal Pharm 3
86問 • 1年前Anticoagulants Pharm
Anticoagulants Pharm
Two Clean Queens · 46問 · 1年前Anticoagulants Pharm
Anticoagulants Pharm
46問 • 1年前Herbals
Herbals
Two Clean Queens · 48問 · 1年前Herbals
Herbals
48問 • 1年前N5220 Exam Pearls
N5220 Exam Pearls
Two Clean Queens · 100問 · 1年前N5220 Exam Pearls
N5220 Exam Pearls
100問 • 1年前DRIQ
DRIQ
Two Clean Queens · 67問 · 1年前DRIQ
DRIQ
67問 • 1年前Clinical Pearls Test 2
Clinical Pearls Test 2
Two Clean Queens · 76問 · 1年前Clinical Pearls Test 2
Clinical Pearls Test 2
76問 • 1年前Test 2 Seidel's Part I
Test 2 Seidel's Part I
Two Clean Queens · 94問 · 1年前Test 2 Seidel's Part I
Test 2 Seidel's Part I
94問 • 1年前Test 2 Seidel's Part II
Test 2 Seidel's Part II
Two Clean Queens · 98問 · 1年前Test 2 Seidel's Part II
Test 2 Seidel's Part II
98問 • 1年前NURS 5112 Exam Review Part 1
NURS 5112 Exam Review Part 1
Two Clean Queens · 66問 · 1年前NURS 5112 Exam Review Part 1
NURS 5112 Exam Review Part 1
66問 • 1年前NURS 5140 Exam 1 Review Part 1
NURS 5140 Exam 1 Review Part 1
Two Clean Queens · 100問 · 1年前NURS 5140 Exam 1 Review Part 1
NURS 5140 Exam 1 Review Part 1
100問 • 1年前NURS 5140 Exam 1 Review Application Part 1
NURS 5140 Exam 1 Review Application Part 1
Two Clean Queens · 100問 · 1年前NURS 5140 Exam 1 Review Application Part 1
NURS 5140 Exam 1 Review Application Part 1
100問 • 1年前NURS 5410 Exam 1 ApplicationPart 2
NURS 5410 Exam 1 ApplicationPart 2
Two Clean Queens · 50問 · 1年前NURS 5410 Exam 1 ApplicationPart 2
NURS 5410 Exam 1 ApplicationPart 2
50問 • 1年前Exam 2 NURS 5140
Exam 2 NURS 5140
Two Clean Queens · 8問 · 1年前Exam 2 NURS 5140
Exam 2 NURS 5140
8問 • 1年前NURS 5112 Exam 2 ChatGPT
NURS 5112 Exam 2 ChatGPT
Two Clean Queens · 90問 · 1年前NURS 5112 Exam 2 ChatGPT
NURS 5112 Exam 2 ChatGPT
90問 • 1年前Exam 3 NURS 5410 Anxiety
Exam 3 NURS 5410 Anxiety
Two Clean Queens · 66問 · 1年前Exam 3 NURS 5410 Anxiety
Exam 3 NURS 5410 Anxiety
66問 • 1年前Exam 3 NURS 5410 Sleep
Exam 3 NURS 5410 Sleep
Two Clean Queens · 72問 · 1年前Exam 3 NURS 5410 Sleep
Exam 3 NURS 5410 Sleep
72問 • 1年前NURS 5410 Exam 3 Quizzes
NURS 5410 Exam 3 Quizzes
Two Clean Queens · 25問 · 1年前NURS 5410 Exam 3 Quizzes
NURS 5410 Exam 3 Quizzes
25問 • 1年前Psychopharm Exam 1
Psychopharm Exam 1
Two Clean Queens · 71問 · 1年前Psychopharm Exam 1
Psychopharm Exam 1
71問 • 1年前Gero Psych Exam 1
Gero Psych Exam 1
Two Clean Queens · 62問 · 1年前Gero Psych Exam 1
Gero Psych Exam 1
62問 • 1年前Psychopharmacology Exam 2 (part 1)
Psychopharmacology Exam 2 (part 1)
Two Clean Queens · 19問 · 1年前Psychopharmacology Exam 2 (part 1)
Psychopharmacology Exam 2 (part 1)
19問 • 1年前Peds Psych Exam 2 (part 1)
Peds Psych Exam 2 (part 1)
Two Clean Queens · 19問 · 1年前Peds Psych Exam 2 (part 1)
Peds Psych Exam 2 (part 1)
19問 • 1年前Peds Psych Exam 2 (part 2)
Peds Psych Exam 2 (part 2)
Two Clean Queens · 50問 · 1年前Peds Psych Exam 2 (part 2)
Peds Psych Exam 2 (part 2)
50問 • 1年前Peds Psych Exam 2 (part 3)
Peds Psych Exam 2 (part 3)
Two Clean Queens · 67問 · 1年前Peds Psych Exam 2 (part 3)
Peds Psych Exam 2 (part 3)
67問 • 1年前Peds Psych Exam 2 (part 4)
Peds Psych Exam 2 (part 4)
Two Clean Queens · 20問 · 1年前Peds Psych Exam 2 (part 4)
Peds Psych Exam 2 (part 4)
20問 • 1年前Psychopharmacology Exam 2 (part 2)
Psychopharmacology Exam 2 (part 2)
Two Clean Queens · 80問 · 1年前Psychopharmacology Exam 2 (part 2)
Psychopharmacology Exam 2 (part 2)
80問 • 1年前Psychopharmacology Exam 2 (part 3)
Psychopharmacology Exam 2 (part 3)
Two Clean Queens · 46問 · 1年前Psychopharmacology Exam 2 (part 3)
Psychopharmacology Exam 2 (part 3)
46問 • 1年前Psychopharmacology Exam 2 (part 4)
Psychopharmacology Exam 2 (part 4)
Two Clean Queens · 22問 · 1年前Psychopharmacology Exam 2 (part 4)
Psychopharmacology Exam 2 (part 4)
22問 • 1年前Psychopharm Depressive Disorders
Psychopharm Depressive Disorders
Two Clean Queens · 86問 · 11ヶ月前Psychopharm Depressive Disorders
Psychopharm Depressive Disorders
86問 • 11ヶ月前Psychopharm Bipolar Disorder
Psychopharm Bipolar Disorder
Two Clean Queens · 58問 · 11ヶ月前Psychopharm Bipolar Disorder
Psychopharm Bipolar Disorder
58問 • 11ヶ月前Psychopharm Anxiety Disorders
Psychopharm Anxiety Disorders
Two Clean Queens · 32問 · 11ヶ月前Psychopharm Anxiety Disorders
Psychopharm Anxiety Disorders
32問 • 11ヶ月前Child Psych Anxiety
Child Psych Anxiety
Two Clean Queens · 56問 · 11ヶ月前Child Psych Anxiety
Child Psych Anxiety
56問 • 11ヶ月前Child Psych OCD/Gen Dysph
Child Psych OCD/Gen Dysph
Two Clean Queens · 34問 · 11ヶ月前Child Psych OCD/Gen Dysph
Child Psych OCD/Gen Dysph
34問 • 11ヶ月前Child Psych Eating Disorders 1
Child Psych Eating Disorders 1
Two Clean Queens · 49問 · 11ヶ月前Child Psych Eating Disorders 1
Child Psych Eating Disorders 1
49問 • 11ヶ月前Child Psych Eating Disorders 2
Child Psych Eating Disorders 2
Two Clean Queens · 14問 · 11ヶ月前Child Psych Eating Disorders 2
Child Psych Eating Disorders 2
14問 • 11ヶ月前Gero Mood Disorders
Gero Mood Disorders
Two Clean Queens · 19問 · 11ヶ月前Gero Mood Disorders
Gero Mood Disorders
19問 • 11ヶ月前Gero Anxiety Disorders
Gero Anxiety Disorders
Two Clean Queens · 13問 · 11ヶ月前Gero Anxiety Disorders
Gero Anxiety Disorders
13問 • 11ヶ月前Gero OCD & PTSD
Gero OCD & PTSD
Two Clean Queens · 15問 · 11ヶ月前Gero OCD & PTSD
Gero OCD & PTSD
15問 • 11ヶ月前Psychopharm Sleep
Psychopharm Sleep
Two Clean Queens · 34問 · 10ヶ月前Psychopharm Sleep
Psychopharm Sleep
34問 • 10ヶ月前Psychopharm ADHD
Psychopharm ADHD
Two Clean Queens · 20問 · 10ヶ月前Psychopharm ADHD
Psychopharm ADHD
20問 • 10ヶ月前Psychopharm Eating Disorders
Psychopharm Eating Disorders
Two Clean Queens · 6問 · 10ヶ月前Psychopharm Eating Disorders
Psychopharm Eating Disorders
6問 • 10ヶ月前Psychopharm Reward and Pleasure
Psychopharm Reward and Pleasure
Two Clean Queens · 32問 · 10ヶ月前Psychopharm Reward and Pleasure
Psychopharm Reward and Pleasure
32問 • 10ヶ月前Psychopharm Impulsivity/Compulsvity/Addiction
Psychopharm Impulsivity/Compulsvity/Addiction
Two Clean Queens · 7問 · 10ヶ月前Psychopharm Impulsivity/Compulsvity/Addiction
Psychopharm Impulsivity/Compulsvity/Addiction
7問 • 10ヶ月前Gero Exam 4 Review
Gero Exam 4 Review
Two Clean Queens · 81問 · 10ヶ月前Gero Exam 4 Review
Gero Exam 4 Review
81問 • 10ヶ月前Child Psych Sleep/Wake Disorders
Child Psych Sleep/Wake Disorders
Two Clean Queens · 58問 · 10ヶ月前Child Psych Sleep/Wake Disorders
Child Psych Sleep/Wake Disorders
58問 • 10ヶ月前Child Psych ODD/CD/SUD
Child Psych ODD/CD/SUD
Two Clean Queens · 49問 · 10ヶ月前Child Psych ODD/CD/SUD
Child Psych ODD/CD/SUD
49問 • 10ヶ月前問題一覧
1
Applying a local anesthetic to numb the tissue and block nociceptive signaling from the site of injury
2
To alert the body to potential tissue damage and prevent further harm
3
Prescribing a medication that targets nerve pain, such as an anticonvulsant, to manage ongoing neuropathic sensations
4
Persistent pain due to nerve damage, often causing burning or shooting sensations without external triggers
5
Utilizing psychotherapy to address emotional distress and reduce the mind-body manifestation of pain
6
Pain that arises without physical damage, linked to emotional or mental distress
7
Providing a local anesthetic for nociceptive pain and prescribing an anticonvulsant for neuropathic pain
8
Psychogenic pain arises from psychological causes, whereas nociceptive and neuropathic pain have physical origins
9
Aδ fibers
10
Sharp, immediate pain in response to injury
11
C fibers
12
Prolonged, dull, and intense pain
13
Aβ fibers for touch, Aδ fibers for quick pain, and C fibers for prolonged pain
14
Aδ fibers carry immediate, sharp pain via myelinated fibers, while C fibers transmit slower, persistent pain through unmyelinated fibers
15
By stimulating Aβ fibers to transmit non-painful signals, which inhibit pain at the spinal cord level
16
Non-painful stimuli activate Aβ fibers, which can inhibit pain signals at the spinal cord level
17
Rubbing activates Aβ fibers, which transmit non-painful signals that inhibit pain transmission in the spinal cord
18
Rubbing stimulates Aβ fibers, which inhibit pain signals at the spinal cord level
19
Dorsal horn neurons in the spinothalamic tract projecting to the thalamus and primary somatosensory cortex
20
Spinothalamic tract, where dorsal horn neurons project to the thalamus and primary somatosensory cortex
21
Sensory/discriminatory pathway
22
To enable the brain to identify where pain is occurring and assess its severity
23
Affective-motivational pathway, where neurons in the spinobulbar tract project to brainstem nuclei, thalamus, and limbic structures
24
Affective-motivational pathway, involving the spinobulbar tract to brainstem nuclei, thalamus, and limbic structures
25
Affective-motivational pathway, which conveys emotional reactions and avoidance motivations related to pain
26
To transmit emotional and motivational responses, creating the desire to avoid the painful stimulus
27
Combining cognitive-behavioral therapy (CBT) for emotional processing with analgesics for pain reduction, addressing both pathways in pain perception
28
The integration of sensory/discriminatory and affective/motivational pathways, combining physical and emotional dimensions
29
Implementing a multimodal approach that combines analgesics to manage physical pain with cognitive-behavioral therapy (CBT) to address the emotional context of pain
30
To process sensory and emotional dimensions together, making pain a fully conscious experience
31
Applying anti-inflammatory medication to reduce swelling and manage pain as the injury heals
32
It results from direct injury and typically resolves once the underlying cause heals
33
Encouraging the use of cognitive-behavioral therapy (CBT) to address central sensitization and coping strategies for persistent pain
34
Chronic pain persists beyond normal healing periods and involves changes in pain pathways
35
Encouraging physical therapy for the wrist sprain while recommending cognitive-behavioral therapy (CBT) to help the patient with chronic back pain manage long-term discomfort
36
Acute pain is a response to direct injury with a clear healing timeline, whereas chronic pain persists due to sensitization and often lacks a defined endpoint
37
Monitoring respiratory function due to the risk of respiratory depression
38
To mediate pain relief, euphoria, and respiratory depression when activated by opioids
39
Improved mood regulation with additional analgesic effects and potentially fewer side effects
40
To modulate mood and provide additional pain relief, often with fewer side effects than mu receptors
41
Kappa receptors cause dysphoria and can lead to hallucinations, which may limit their use
42
They induce pain relief but are often accompanied by dysphoria and potential hallucinations
43
Kappa receptors, as they provide pain relief without euphoria, though they may cause dysphoria
44
Mu receptors are most commonly targeted for their potent pain relief but have a higher addiction risk compared to delta and kappa receptors